We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+8.22%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
–
Cap. Flow
+$100M
Cap. Flow %
100.06%
Top 10 Hldgs %
20.66%
Holding
249
New
249
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$2.64M
2
INVH icon
Invitation Homes
INVH
+$2.51M
3
MBB icon
iShares MBS ETF
MBB
+$2.48M
4
EEFT icon
Euronet Worldwide
EEFT
+$2.17M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.01M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 40.96%
2 Technology 10.32%
3 Real Estate 9.94%
4 Industrials 7.65%
5 Financials 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EMB icon
76
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.6B
$422K 0.42%
+4,380
New +$421K
VYM icon
77
Vanguard High Dividend Yield ETF
VYM
$80B
$418K 0.42%
+2,913
New +$414K
CWB icon
78
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.78B
$417K 0.42%
+4,678
New +$425K
WSR
79
DELISTED
Whitestone REIT
WSR
$417K 0.42%
+30,000
New +$387K
REM icon
80
iShares Mortgage Real Estate ETF
REM
$559M
$410K 0.41%
+18,493
New +$411K
BBAI icon
81
BigBear.ai
BBAI
$1.36B
$405K 0.4%
+75,000
New +$490K
MBOT icon
82
Microbot Medical
MBOT
$118M
$400K 0.4%
+200,000
New +$474K
AHRT
83
AH Realty Trust
AHRT
$535M
$397K 0.4%
+60,000
New +$396K
AMPX icon
84
Amprius Technologies
AMPX
$1.44B
$395K 0.39%
+50,000
New +$572K
KYMR icon
85
Kymera Therapeutics
KYMR
$9.52B
$392K 0.39%
+5,035
New +$340K
NEM icon
86
Newmont
NEM
$95.8B
$382K 0.38%
+3,828
New +$346K
PSNL icon
87
Personalis
PSNL
$1.61B
$380K 0.38%
+47,796
New +$418K
EWTX icon
88
Edgewise Therapeutics
EWTX
$4.28B
$365K 0.36%
+14,703
New +$295K
PONY
89
Pony AI Inc
PONY
$2.89B
$363K 0.36%
+25,000
New +$416K
AGIO icon
90
Agios Pharmaceuticals
AGIO
$2.36B
$358K 0.36%
+13,141
New +$461K
DPRO
91
Draganfly
DPRO
$155M
$346K 0.34%
+50,000
New +$422K
NRIX icon
92
Nurix Therapeutics
NRIX
$2.4B
$344K 0.34%
+18,134
New +$261K
ADMA icon
93
ADMA Biologics
ADMA
$2.02B
$343K 0.34%
+18,782
New +$317K
UAL icon
94
United Airlines
UAL
$37.5B
$341K 0.34%
+3,050
New +$308K
XERS icon
95
Xeris Biopharma Holdings
XERS
$1.52B
$341K 0.34%
+43,392
New +$342K
GM icon
96
General Motors
GM
$68.6B
$339K 0.34%
+4,167
New +$294K
CYTK icon
97
Cytokinetics
CYTK
$10.9B
$337K 0.34%
+5,311
New +$330K
COR icon
98
Cencora
COR
$59.9B
$336K 0.33%
+995
New +$339K
ORKA
99
Oruka Therapeutics
ORKA
$5.59B
$330K 0.33%
+10,880
New +$303K
BNY
100
Bank of New York Mellon
BNY
$108B
$329K 0.33%
+2,832
New +$313K
2 3
4
5 6

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q4 2025 Portfolio in Review

Q4 2025 is the first quarter with a 13F filing on record for AlphaCentric Advisors, which disclosed 249 positions worth $100M. Its ten largest holdings account for 21% of the portfolio.

Its largest position is Gilead Sciences: 21,761 shares worth $2.67M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, followed by Technology and Real Estate.

  • AlphaCentric Advisors's largest Q4 2025 buy was Gilead Sciences: 21,761 shares worth $2.67M.
  • AlphaCentric Advisors's ten largest holdings make up 21% of its $100M portfolio in Q4 2025.
  • AlphaCentric Advisors disclosed 249 positions in Q4 2025, its first 13F filing on record.

Based on AlphaCentric Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.